Robert S Libauer insider trades: Puramed Bioscience (PMBS) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 29, 2013 | PMBS | ↑ Buy | 689,552 | $0.02 | $14K | Direct | Aug 14, 2013 (16d) |
| Feb 7, 2013 | PMBS | ↑ Buy | 5,459,552 | $0.04 | $224K | Direct | Apr 10, 2013 (62d) |
| Jun 28, 2012 | ITNM | ↑ Buy | 10,000 | $0.68 | $7K | Direct | Jul 11, 2012 (13d) |
| Apr 10, 2012 | ITNM | ↑ Buy | 5,000 | $2.59 | $13K | Direct | Apr 13, 2012 (3d) |
| Aug 15, 2011 | ITNM | ↑ Buy | 5,000 | $0.73 | $4K | Direct | Nov 28, 2011 (105d) |
| May 13, 2011 | ITNM | ↑ Buy | 12,000 | $0.68 | $8K | Direct | May 19, 2011 (6d) |
| May 13, 2011 | INTM | ↑ Buy | 2,000 | $0.70 | $1K | Direct | May 18, 2011 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Robert S Libauer's insider trades
Robert S Libauer is a 10% owner of Puramed Bioscience (PMBS). Since May 13, 2011, Robert has reported 7 open-market purchases worth $271K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PMBS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.